Expand RVMD Menu
RVMD MENU

RVMD Stock Posts


Upcoming Earnings

RVMD Revolution Medicines58.12-0.45 (-0.8%)

Revolution Medicines will report earnings after the market closes. View Calendar The market is expecting a ±9.0% move after earnings are reported. The average move for the past 4 quarters of earnings has been ±5.0%. View Expected Move (Conf Call: Nov 5 4:30 PM)
RVMD #RevolutionMedicines stock increases 7.9% after hours.

After Hours Gainer

RVMD Revolution Medicines49.68+0.12+0.2%

After Hours:53.61+3.93 (+7.9%)

Revolution Medicines Awarded Voucher for Daraxonrasib (RMC-6236) Under FDA Commissioner's National Priority Voucher Pilot Program

Globe NewswireThu, 16-Oct 8:00 PM
RVMD #RevolutionMedicines stock increases 8.0% after hours.

After Hours Gainer

RVMD Revolution Medicines40.45-0.49-1.2%

After Hours:43.70+3.25 (+8.0%)

Revolution Medicines Shares New Clinical Results Supporting Initiation of RASolute 303, a Global Phase 3 Registrational Trial of Daraxonrasib in First Line Metastatic Pancreatic Ductal Adenocarcinoma

Globe NewswireWed, 10-Sep 4:02 PM
RVMD #RevolutionMedicines stock increases 7.5% after hours.

After Hours Gainer

RVMD Revolution Medicines40.45-0.49-1.2%

After Hours:43.50+3.05 (+7.5%)

Revolution Medicines Shares New Clinical Results Supporting Initiation of RASolute 303, a Global Phase 3 Registrational Trial of Daraxonrasib in First Line Metastatic Pancreatic Ductal Adenocarcinoma

Globe NewswireWed, 10-Sep 4:02 PM
Unusual Option Volume

RVMD Revolution Medicines39.30+1.33 (+3.5%)

Revolution Medicines trades 3,875 contracts.
View Details...

RVMD 35.82-0.85 (-2.3%)Revolution Medicines
Load Earlier Posts
Market Data Delayed 15 Minutes